Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type ... and irreversible inhibitor of MAO-B that has demonstrated ...

Tobacco and coffee contain bioactive compounds that may reduce Parkinson's disease risk by targeting key pathways such as MAO ...

Am J Health Syst Pharm. 2006;63(10):915-928. Results of this study suggest that adjunctive rasagiline significantly reduces off time with efficacy similar to that observed by adding entacapone to ...

double-blind trial evaluating the efficacy and safety of prasinezumab compared with placebo in 586 randomised patients with early-stage Parkinson's disease who were on stable symptomatic treatment ...

is a new reversible selective monoamine oxidase B (MAO-B) inhibitor being studied for its potential in treating neurodegenerative diseases like Alzh The ongoing obesity Phase 2 trial is a ...

are taking or have taken medicines called monoamine oxidase inhibitors (MAOIs) in the past 14 days; or are allergic to any of the ingredients in CONTRAVE. Tell your healthcare provider about all ...

The participants were on stable levodopa or monoamine oxidase-B inhibitor monotherapy for more than three months before enrollment. Study participants received prasinezumab or placebo every 4 weeks ...

since dealcoholization doesn’t remove these compounds Are on monoamine oxidase inhibitors (MAOIs), since dealcoholized wine may still be high in tyramine “A truly alcohol-free drink that never ...

If you’ve been diagnosed with clinical depression, also known as major depressive disorder (MDD), rest assured there are many treatment options available. Some people will experience only one ...